Blog

Sterile injectable fill-finish is where CMC either protects patients and timelines, or quietly accumulates risk until it becomes a deviation, an investigation, or a regulatory delay. When we outsource to a European CDMO, the documentation set has to do two […]

When an injectable solution is administered, it bypasses the patient’s normal protective barriers. Skin and the digestive system no longer act as filters. At that point, the primary packaging becomes the barrier. That is the starting point for any sterility […]